Variable efficacy of the non-covalent KRASG12D inhibitor (MRTX-1133) with obesity in murine pancreatic cancer
- DOI
- 10.1038/s41698-026-01493-z
- Published
- 2026-06-08
- Container
- npj Precision Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41698-026-01493-z,
title = {Variable efficacy of the non-covalent KRASG12D inhibitor (MRTX-1133) with obesity in murine pancreatic cancer},
author = {Sujith Sarvesh and Holly Stephens and Pia Muri and Henry Nnaemeka Ogbonna and Jianqing Zhang and Karen Aikhionbare and Dhana Sekar Reddy Bandi and Cherlene Hardy and Ganji Purnachandra Nagaraju and Bassel F. El-Rayes and Lyse A. Norian and Jeremy B. Foote},
year = {2026},
journal = {npj Precision Oncology},
doi = {10.1038/s41698-026-01493-z},
url = {https://doi.org/10.1038/s41698-026-01493-z}
}RIS
TY - JOUR TI - Variable efficacy of the non-covalent KRASG12D inhibitor (MRTX-1133) with obesity in murine pancreatic cancer AU - Sujith Sarvesh AU - Holly Stephens AU - Pia Muri AU - Henry Nnaemeka Ogbonna AU - Jianqing Zhang AU - Karen Aikhionbare AU - Dhana Sekar Reddy Bandi AU - Cherlene Hardy AU - Ganji Purnachandra Nagaraju AU - Bassel F. El-Rayes AU - Lyse A. Norian AU - Jeremy B. Foote PY - 2026 JO - npj Precision Oncology DO - 10.1038/s41698-026-01493-z UR - https://doi.org/10.1038/s41698-026-01493-z ER -
APA
Sarvesh, S., Stephens, H., Muri, P., Ogbonna, H. N., Zhang, J., Aikhionbare, K., Bandi, D. S. R., Hardy, C., Nagaraju, G. P., El-Rayes, B. F., Norian, L. A., & Foote, J. B. (2026). Variable efficacy of the non-covalent KRASG12D inhibitor (MRTX-1133) with obesity in murine pancreatic cancer. npj Precision Oncology. https://doi.org/10.1038/s41698-026-01493-z
Source records
- crossref · retrieved 2026-09-26T16:18:27.744Z